source
- Novartis' radioligand therapy Lutathera could soon face generic competitionThe radioligand field is on the cusp of a major competitive moment, as a rival looks to bring the first generic to a market that’s been dominated by Novartis. Radioligand therapy aims to bring the ...Endpoints · 4mo ago↗ source
- Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campusThe 185-acre site will be the company’s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.BioPharma Dive · 4mo ago↗ source
- STAT+: Legislatures in Colorado and Virginia resist moves to constrain drug affordability boardsLegislators in two states are resisting efforts to restrict prescription drug affordability boards.STAT